GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OrganiGram Holdings Inc (FRA:0OG0) » Definitions » 10-Year RORE %

OrganiGram Holdings (FRA:0OG0) 10-Year RORE % : 0.00% (As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is OrganiGram Holdings 10-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. OrganiGram Holdings's 10-Year RORE % for the quarter that ended in Jun. 2024 was 0.00%.

The industry rank for OrganiGram Holdings's 10-Year RORE % or its related term are showing as below:

FRA:0OG0's 10-Year RORE % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.095
* Ranked among companies with meaningful 10-Year RORE % only.

OrganiGram Holdings 10-Year RORE % Historical Data

The historical data trend for OrganiGram Holdings's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrganiGram Holdings 10-Year RORE % Chart

OrganiGram Holdings Annual Data
Trend Apr12 Apr13 Apr14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21
10-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

OrganiGram Holdings Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24 Jun24
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of OrganiGram Holdings's 10-Year RORE %

For the Drug Manufacturers - Specialty & Generic subindustry, OrganiGram Holdings's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrganiGram Holdings's 10-Year RORE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OrganiGram Holdings's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where OrganiGram Holdings's 10-Year RORE % falls into.



OrganiGram Holdings 10-Year RORE % Calculation

OrganiGram Holdings's 10-Year RORE % for the quarter that ended in Jun. 2024 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( - )/( -4.508-0 )
=/-4.508
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jun. 2024 and 10-year before.


OrganiGram Holdings  (FRA:0OG0) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


OrganiGram Holdings 10-Year RORE % Related Terms

Thank you for viewing the detailed overview of OrganiGram Holdings's 10-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


OrganiGram Holdings Business Description

Traded in Other Exchanges
Address
145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.

OrganiGram Holdings Headlines

No Headlines